Aaron Jurrjens 3rd Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity 2022

Abstracts this author is presenting:

• CHARACTERISING TTC39C AS A NOVEL REGULATOR OF HEPATIC LIPID METABOLISM — Poster Session 1